Free supplier Enterprise Certification
Business Type:Lab/Research institutions
Home
Company
Products
Contacts
Product Certification&Enterprise Certification
Country: China (Mainland)
Dupilumab
CAS NO.: 1190264-60-8
Pembrolizumab
CAS NO.: 1374853-91-4
NARSOPLIMAB
CAS NO.: 2108782-45-0
Meplazumab
CAS NO.: 2413715-21-4
Ruplizumab
CAS NO.: 220651-94-5
Apolizumab
CAS NO.: 267227-08-7
Efalizumab
CAS NO.: 339155-58-7
Epratuzumab
CAS NO.: 205923-57-5
Fontolizumab
CAS NO.: 326859-36-3
Gemtuzumab
CAS NO.: 220578-59-6
Cantuzumab
CAS NO.: 400010-39-1
Lintuzumab
CAS NO.: 166089-32-3
Lorvotuzumab
CAS NO.: 1008106-64-6
Labetuzumab
CAS NO.: 219649-07-7
Amatuximab
CAS NO.: 931402-35-6
Naptumomab Estafenatox
CAS NO.: 676258-98-3